Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
Milestone Pharmaceuticals Inc. (MIST) had Return on Equity of 339.07% for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-20.76M |
|
-- |
|
-- |
|
$20.52M |
|
$-20.52M |
|
$-0.24M |
|
$-20.76M |
|
$-20.76M |
|
$-20.76M |
|
$-20.76M |
|
$-20.76M |
|
$-20.76M |
|
$-20.52M |
|
$-20.52M |
|
66.28M |
|
66.28M |
|
$-0.31 |
|
$-0.31 |
|
| Balance Sheet Financials | |
$60.48M |
|
$0.18M |
|
$1.41M |
|
$61.88M |
|
$12.96M |
|
$54.29M |
|
$55.05M |
|
$68.01M |
|
$-6.12M |
|
$-6.12M |
|
$-6.12M |
|
53.46M |
|
| Cash Flow Statement Financials | |
$-13.95M |
|
$33.58M |
|
$0.14M |
|
$25.31M |
|
$45.09M |
|
$19.77M |
|
$1.35M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.67 |
|
-- |
|
-- |
|
1.13 |
|
-8.87 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-13.96M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Return on Equity |
339.07% |
339.07% |
|
-33.55% |
|
-43.10% |
|
$-0.11 |
|
$-0.21 |
|
$-0.21 |
|